| Document |
Document Title |
|
WO/2021/092470A1 |
The present disclosure relates to therapeutic compositions and therapies for use in the treatment of diseases and disorders of the eye. The present disclosure relates to curved, multilayer controlled-release ocular implant devices which ...
|
|
WO/2021/056922A9 |
The invention belongs to the technical field of pesticides and specifically relates to an aryl sulfide containing a benzylamine structure, a synthesis method therefor, and an application thereof. The aryl sulfide is denoted as compound I...
|
|
WO/2021/081634A1 |
A combination that includes: a flavonoid, for example in an amount from about 0.1 g to about 1.5 g; and one or more of: ascorbic acid, ascorbate, or a combination thereof, for example in an amount from about 0.2 g to about 2.0 g; N-acety...
|
|
WO/2021/082501A1 |
Disclosed is expectorant compounds, specifically, compounds represented by formula I and formula II, and a pharmaceutically acceptable salt or a tautomer thereof.
|
|
WO/2021/077194A1 |
The present invention relates to the production of carbonyl compounds and derivatives, by means of high yield and purity syntheses, providing antitumour active principles with selective antiproliferative properties and antimestastatic ac...
|
|
WO/2021/079223A1 |
A composition includes a hydroflourothioether represented by the following structural formula (I): Rf-S-Rh (I) Rf is a fluorinated or perfluorinated group having 2-9 carbon atoms and optionally includes one or more catenated heteroatoms ...
|
|
WO/2021/074108A1 |
The invention relates to a process of preparing 1,1'-disulfandiylbis(4-fluoro-2-methyl-5-nitrobenzol), (l), which is used as an intermediate product for the preparation of phenyl sulfoxides having insecticidal, acaricidal and nematicidal...
|
|
WO/2021/064530A1 |
Described herein is a dicarboxylic acid compound of formula (I): Wherein: R3 comprises an aryl group, R2 is an alkylene group comprising 1 to 6 carbon atoms, n is 0 or 1, R1 is H or CH3, and X is S or NZ, wherein Z is H, an alkyl group c...
|
|
WO/2021/060517A1 |
The present invention provides a novel method for producing a derivative of an organic substance that contains one or more groups selected from the group consisting of a sulfanyl group, a selanyl group and a sulfino group. A method for p...
|
|
WO/2021/052268A1 |
A magnolol derivative, and a preparation method therefor and an application thereof. The magnolol derivative has a structure as shown in formula (1). The magnolol derivative has good water solubility, is colorless and transparent after b...
|
|
WO/2021/054268A1 |
The present specification discloses a method for producing a concentrated carbonate aqueous solution. The present invention relates to a method for producing a concentrated carbonate aqueous solution, comprising a step of dewatering an a...
|
|
WO/2021/049961A1 |
The invention relates to an influenza virus detection kit comprising a buffer, a linker, and an amino acid sequence, and a virus detection method.
|
|
WO/2021/047928A1 |
A process for removing acid gases from a fluid stream, wherein the fluid stream is contacted with an absorbent to obtain a treated fluid stream and a laden absorbent, the absorbent comprising at least one diluent and a compound of the ge...
|
|
WO/2021/046234A1 |
The present disclosure provides processes for preparing an alpha-hydroxy ester from the corresponding alpha-hydroxy acid by transesterification. Also provided are alphahydroxy esters prepared according to processes disclosed herein and c...
|
|
WO/2021/042814A1 |
Disclosed are an alkyl thioether ethyl hydroximic acid beneficiation agent, a preparation method therefor and a use thereof. The alkyl thioether ethyl hydroximic acid molecule has two functional groups, i.e. a thioether group and a hydro...
|
|
WO/2021/042411A1 |
Disclosed are an AKR1C3 inhibitor or a pharmaceutically acceptable salt of same, a preparation method for same, and uses thereof. A structural optimization is performed with a nonsteroidal anti-inflammatory medicament, flurbiprofen, serv...
|
|
WO/2021/043188A1 |
Provided in the present disclosure is a mixture, comprising: 86-89 wt% of a methionine hydroxy analog and an oligomer thereof, more than 99.95 wt% being a monomer, dimer and trimer, and the ratio of monomer:dimer:trimer by weight being 7...
|
|
WO/2021/027933A1 |
The embodiment of the present invention relates to the field of the synthesis of mercapto compounds, in particular to a method for preparing 3-mercaptopropionic acid. The preparation method provided in the present invention comprises: mi...
|
|
WO/2021/030703A1 |
Disclosed herein, inter alia, are depalmitoylating compounds, compositions, and methods of use thereof.
|
|
WO/2021/016535A1 |
A novel Low Free 2-MercaptoEthanol Ester has been used to prepare Alkyl Tin Reverse Ester Stabilizers as well as used to enhance the thermal performance of those Alkyl Tin Reverse Ester Stabilizers or Alkyl Tin Thioglycolate Stabilizers ...
|
|
WO/2021/011334A1 |
The invention provides new deuterated derivatives of 6,8-bis(benzylsulfanyl)octanoic acid, pharmaceutical compositions thereof, and methods for treating cancer with the new compositions.
|
|
WO/2020/258660A1 |
The present application relates to a crystal form of a valnemulin hydrochloride hydrate, a preparation method therefor, and a pharmaceutical composition containing the crystal form. Specifically, the present application relates to a crys...
|
|
WO/2020/262455A1 |
The present invention provides a means for increasing the solubility of even a poorly soluble amino acid without changing to an expensive peptide and also without changing the pH, and is characterized in that at least two kinds of amino ...
|
|
WO/2020/262451A1 |
The invention addresses the problem that metal-organic frameworks have conventionally only been produced with terephthalic acids having a limited range of substituents even though the amount and type of gas stored thereby can vary depend...
|
|
WO/2020/255425A1 |
This anti-HBV agent contains a compound represented by general formula (I) or a compound represented by general formula (II), or a salt thereof.
|
|
WO/2020/254403A1 |
The invention relates to a single cycle process for preparing D,L-methionine from an alkali methioninate solution obtained by alkaline hydrolysis of 5-(2-methylmercaptoethyl)hydantoin, in which the D,L-methionine is obtained by neutraliz...
|
|
WO/2020/251368A1 |
The present invention describes liposome formulations comprising a phospholipid, cholesterol and a fatty acid compound or fatty acid containing compound. Also, various medical uses of the liposome formulation are described.
|
|
WO/2020/249495A1 |
The present invention relates to a process for the preparation of methionine comprising the step of contacting a solution or suspension comprising 2-amino-4-(methylthio)butanenitrile and/or 2-amino- 4-(methylthio)butaneamide with water i...
|
|
WO/2020/244323A1 |
Disclosed are a preparation method for a cis-p-mentha-1,8-secondary amine compound and a herbicidal application thereof. The method comprises: using a cis-p-mentha-1,8-di-schiff base compound as a raw material, putting reducing agents in...
|
|
WO/2020/243986A1 |
The present invention relates to a fluorine-containing alternating copolymer macromonomer and a synthesis method therefor. The method comprises the following steps: carrying out a reduction reaction on a fluorine-containing alternating c...
|
|
WO/2020/229393A1 |
A process for the synthesis of compounds comprising at least one non-cyclic carbonate group is provided, wherein a compound A) comprising at least one five-membered cyclic monothiocarbonate group is reacted with at least one hydroxy grou...
|
|
WO/2020/227079A1 |
This disclosure is directed to the use of a portable Surface Enhance Raman Spectroscopy method to detect, quantify, and/or monitor corrosion inhibitors that are present in fluids in a wide range of concentrations in order to manage corro...
|
|
WO/2020/224767A1 |
The present invention relates to compounds of formula (I) as herein defined, capable of releasing fragrant compounds in a controlled manner into the surroundings. The present invention is also concerned with a process for their productio...
|
|
WO/2020/221607A1 |
A process to produce a mono vinyl thioether by reacting acetylene with a compound comprising one thiol group and one hydroxy group, hereinafter referred to as thiol-hydroxy compound, wherein the reaction is performed at a pressure below ...
|
|
WO/2020/218508A1 |
The thiol-containing composition for an optical material of the present invention includes a compound (A) represented by general formula (a) and a compound (B) comprising at least one selected from compounds (b2-1) represented by general...
|
|
WO/2020/218527A1 |
An ionic solid having void spaces in which a substance is to be incorporated.
|
|
WO/2020/212543A1 |
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive unit, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalm...
|
|
WO/2020/214946A1 |
The present invention provides, in part cystine cationic lipid compounds of formula A, and sub-formulas thereof: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mR...
|
|
WO/2020/208594A1 |
The present invention provides various solid state forms of elafibranor. In an aspect of present invention provides a stable amorphous form of elafibranor and its processes. The present invention also provides a stable admixture form of ...
|
|
WO/2020/201412A1 |
The invention relates to a method for preparing a compound of formula (I) [Chem I], in which X is chosen among S, Se; R1 is chosen from among the alkyl, aryl, alkylaryl and heteroaryl groups, optionally carriers of one or more function, ...
|
|
WO/2020/198573A1 |
The present disclosure relates to compounds of Formula (I) or (II): (Formulae (I), (II)), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compou...
|
|
WO/2020/175838A1 |
Disclosed is a novel diamine compound comprising a structure in which diphenyl sulfide in a molecule is bonded through an amide bond to a phenyl ring substituted with an amine group. A polyimide film prepared by polymerizing the novel di...
|
|
WO/2020/168385A1 |
The present invention relates to a method of preparing N-acyl amino acids selected from N-acyl cysteine compounds, N-acyl serine compounds, N-acyl aspartic acid compounds and N-acyl glutamic acid compounds. The present invention also rel...
|
|
WO/2020/161074A1 |
The invention refers to the use of a particulate catalyst containing 60.0 to 99.5 wt.% ZrO2 stabilised with an oxide of the element Hf and at least one oxide of the element M, wherein M = Ce, Si, Ti, or Y, for the hydrolysis reaction of ...
|
|
WO/2020/161067A1 |
The present invention relates to a process for the preparation of methionine comprising the step of contacting a solution or suspension comprising 2-amino-4-(methylthio)butanenitrile and/or 2-amino-4-(methylthio)butaneamide with water in...
|
|
WO/2020/157463A1 |
Disulphide compounds of Formula (I) where Y is sulphuryl or sulphinyl Z is phenyl or substituted phenyl and the other variables are as defined in the claims; pharmaceutical compositions comprising these compounds and methods for making t...
|
|
WO/2020/154160A1 |
A composition comprising a compound having the general formula (I): F – [CF2]n – (O[CF2]n)m –( L )p – SH (Formula (I)) Each n is independently from 2 to 4, m is from 3 to 30, p is 0 or 1 and L represents a linker having the formu...
|
|
WO/2020/148617A1 |
The present invention disclosed 3-substituted phenylamidine compounds of general formula (I), wherein R1, R2, R3, R4, R4a, R4b, A and E have the same meanings as defined in description. The present invention further discloses methods for...
|
|
WO/2020/148509A1 |
The invention relates to an agent for initiating a radical addition reaction, comprising or consisting of a persulfate and one or more transition metals, in elemental form or in an oxidized form, and to a process for preparing a compound...
|
|
WO/2020/145111A1 |
An objective of the present invention is to provide: a novel thiol compound; a method for synthesizing said thiol compound; a curing agent containing said thiol compound; a resin composition containing said thiol compound and an epoxy co...
|
